GoPro Takeout at $1.14 Per Share Faces Fairness Scrutiny as Halper Sadeh Probes Working-Capital Adjustment

What happened

Law firm Halper Sadeh announced it is investigating the sale of GoPro to Starman Optical for $1.14 per share, subject to a net working capital adjustment at closing. The announcement follows months of deteriorating fundamentals: GoPro's subscribers fell to 2.42M (-5% y/y) in Q3'25, sell-through dropped 18% y/y, and the company faced covenant ramps tied to a $50M secured term loan. The proposed price of $1.14 sits above the last reported trading price of $0.8066 (as of Feb 2026) and below our prior bull-case scenario of $1.40, implying limited upside from operational recovery. The working-capital adjustment injects uncertainty, as GoPro's restricted cash and fully drawn revolver as of Q3'25 could reduce net proceeds to shareholders. The law firm's investigation suggests potential process concerns, but no formal legal challenge has been filed yet.

Implication

The takeout prices in a recovery that fundamentals haven't yet shown: subscribers and revenue were still declining as of the latest quarter, and the sale removes covenant risk but also caps upside at $1.14. The working-capital adjustment could erode final consideration, especially given restricted cash and fully drawn borrowing. The law firm probe suggests possible process deficiencies that could lead to a higher offer or a break-up fee scenario. Investors should await the proxy statement and fairness opinion, then compare the deal value against our bear/base/bull scenario range of $0.55/$0.90/$1.40. If the deal closes at $1.14, it validates our view that covenant pressure forced a sale below intrinsic potential, and long-term holders may have been better served by a covenant waiver or refinancing instead of a fire-sale exit.

Thesis delta

Our prior WAIT rating rested on a leveraged turnaround with binary covenant risk; the announced sale at $1.14 per share materially lowers that risk but converts the thesis to a merger-arb spread. The working-capital adjustment and fairness investigation add path dependency, so we would no longer assess standalone value but rather probability-weighted deal completion and potential bump. We shift our stance from WAIT to HOLD/REVIEW pending definitive merger terms.